Watch CBS News

Johnson & Johnson releases results from phase three single-dose COVID-19 vaccine trials

Name: Johnson & Johnson releases results from phase three single-dose COVID-19 vaccine trials
Uploaded: 2021-01-29T08:02:11-0500
Duration: 5 min 39 s
Description: Johnson & Johnson announced that their new single-dose vaccine showed 85% protection against severe cases of COVID-19. Some advantages of the new vaccine: it's a single dose and can be stored in a regular refrigerator. Dr.Tara Narula details how this new vaccine works.

Johnson & Johnson announced that their new single-dose vaccine showed 85% protection against severe cases of COVID-19. Some advantages of the new vaccine: it's a single dose and can be stored in a regular refrigerator. Dr.Tara Narula details how this new vaccine works.